Showing 1 - 8 of 8
factors of success in drug development programs at different stages of innovation process. We use economies of scale, scope, R … a project differs in relation to the discovery and development stages of innovation, respectively. Our main finding is … discovery stage of innovation, while in the later development stage, the effects of competition outweigh any benefits from …
Persistent link: https://www.econbiz.de/10010270028
This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the …
Persistent link: https://www.econbiz.de/10010266682
This paper empirically investigates the determinants of R&D diversification strategies in the drug industry. It enriches the existing literature by proposing to look at diversification factors, which reflect market and technological proximity of an R&D project towards other projects within a...
Persistent link: https://www.econbiz.de/10010267114
This paper aims to investigate the effect of knowledge characteristics on the total factor productivity of firms developing drugs in the pharmaceutical industry. We decompose knowledge into knowledge associated with the technological firm portfolio and knowledge related to R&D projects, which...
Persistent link: https://www.econbiz.de/10010270030
This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the …
Persistent link: https://www.econbiz.de/10004961229
factors of success in drug development programs at different stages of innovation process. We use economies of scale, scope, R … a project differs in relation to the discovery and development stages of innovation, respectively. Our main finding is … discovery stage of innovation, while in the later development stage, the effects of competition outweigh any benefits from …
Persistent link: https://www.econbiz.de/10008511329
This paper aims to investigate the effect of knowledge characteristics on the total factor productivity of firms developing drugs in the pharmaceutical industry. We decompose knowledge into knowledge associated with the technological firm portfolio and knowledge related to R&D projects, which...
Persistent link: https://www.econbiz.de/10008511333
This paper empirically investigates the determinants of R&D diversification strategies in the drug industry. It enriches the existing literature by proposing to look at diversification factors, which reflect market and technological proximity of an R&D project towards other projects within a...
Persistent link: https://www.econbiz.de/10008481990